Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-11T01:02:19.456Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Aspects of the Use of Anti-lymphocytic Serum

Published online by Cambridge University Press:  11 June 2012

B. Nolan
B. Nolan
Affiliation:
Department of Surgical Science, Edinburgh University Medical School
Get access

Extract

The fundamental problem in transplant surgery is that of preventing the immunological reaction which invariably occurs when an organ is transplanted between individuals, other than identical twins, and which brings about the destruction of the transplant. This reaction can be suppressed by a variety of agents but none of them is entirely satisfactory and there is a great need to find new ones which will be more effective and, in particular, more specific in their action. It was for this reason that anti-lymphocytic serum was first developed.

Type
Research Article
Information
Proceedings of the Royal Society of Edinburgh, Section B: Biological Sciences , Volume 70 , Issue 4 , 1969 , pp. 341 - 345
Copyright
Copyright © Royal Society of Edinburgh 1969

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References to Literature

Abaza, H. M., Nolan, B., Watt, J. G., and Woodruff, M. F. A., 1966. “The effect of anti-lymphocytic serum on the survival of renal homotransplants in dogs”. Transplantation, 4, 618–632.CrossRefGoogle Scholar
Clunie, G. J. A., Nolan, B., James, K., Watt, J. G., and Woodruff, M. F. A., 1968. “Prolongation of canine renal allografts with anti-lymphocytic serum”, Transplantation, 6, 459–467.CrossRefGoogle Scholar
Monaco, A. P., Abbott, W. N., Otherson, H. B., Simmons, R. L., Wood, M. L., Flax, M. H., and Russell, P. S., 1966. “Antiserum to lymphocytes: Prolonged survival of canine renal allografts”, Science, N.Y., 153, 1264–1267.CrossRefGoogle ScholarPubMed
Monaco, A. P., Wood, M. L., Werf, B. A. Van Der, and Russell, P. S., 1967. “Effect of anti-lymphocytic serum in mice, dogs and man”. Ciba Fdn Study Grps, Anti Lymphocytic Serum, 29, 111–134.Google Scholar
Starzl, T. E., Groth, C. G., Terasaki, P. I., Putnam, C. W., Brettschneider, L., and Marchioro, T. L., 1968. “Heterologous antilymphocyte globulin, histocompatibility matching, and human renal homotransplantation”, Surgical Gynec. Obstet., 126, 1023–1035.Google Scholar
Starzl, T. E., Marchioro, T. L., Porter, K. A., Iwasaki, Y., and Cerrilli, C. J., 1967. “The use of heterologous anti-lymphoid agents in canine renal and liver homotransplantation and in human renal transplantation”, Surgical Gynec. Obstet., 124, 301–318.Google Scholar